Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Experimental Validation of the Virtual Eggs Test (VET) in the Pediatric Population

NCT: NCT07793032 · NOT_YET_RECRUITING

NCT IDNCT07793032
StatusNOT_YET_RECRUITING
Start Date2026-09-01
Completion2026-11-30
SponsorIRCCS Fondazione Stella Maris (OTHER)
First posted
Last updated

Brief Summary

This study aims to investigate the validity of the Virtual Egg Test (VET) for the assessment of manual dexterity in children and adolescents with cerebral palsy and developmental coordination disorder (experimental group), including a typically developing group for the collection and establishment of normative values (control group). The clinical site where the study procedures for the experimental group will be conducted is the IRCCS Fondazione Stella Maris in Calambrone (Pisa), Italy. Participants of both sexes and of any ethnicity, aged between 6 and 21 years at the time of recruitment, will be selected according to specific inclusion criteria. The study protocol consists of two assessment sessions scheduled at an interval of at least 3 days and no more than 5 days. During the first assessment session (T0), standardized and non-standardized assessment procedures will be administered. First, the Virtual Egg Test (VET) will be administered using the Virtual Egg (VE). The VE is a parallelepiped-shaped device equipped with an internal magnetic mechanism that maintains the walls of the object in a predefined, non-collapsed position. When the grip force exceeds the attractive force between the two magnets, the external walls move closer together, causing the "VE to break" reversibly. The sensorized platform comprises three distinct sensitive areas: the starting position and two target areas for placing the VEs. The areas are separated by a 6-cm-high barrier. Subsequently, standardized clinical assessment tests will be administered. During the second assessment session (T1), the Virtual Egg Test (VET) will be administered, followed by a feasibility questionnaire specifically developed for this study regarding its use. The questionnaire will be completed by both the participant and the clinical staff.

Frequently Asked Questions

What is Experimental Validation of the Virtual Eggs Test (VET) in the Pediatric Population?

Experimental Validation of the Virtual Eggs Test (VET) in the Pediatric Population is a clinical trial registered under NCT07793032. Current status: NOT_YET_RECRUITING.

What is the status of NCT07793032?

The current status of NCT07793032 (Experimental Validation of the Virtual Eggs Test (VET) in the Pediatric Population) is: NOT_YET_RECRUITING.

When did Experimental Validation of the Virtual Eggs Test (VET) in the Pediatric Population start?

Experimental Validation of the Virtual Eggs Test (VET) in the Pediatric Population started on 2026-09-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.